danielaletaha.bsky.social
Rheumatologist, Medical University Vienna - Past-President of EULAR
👤 Joined on 22 January 2025
Followers
Following
Total Posts
@danielaletaha.bsky.social💊 #Methotrexate has been the mainstay of treatment for #RheumatoidArthritis. Researchers at #MedUniVienna analysed how the drug alters the #immunesystem during the first few weeks of treatment. ⬇️ 💡 MTX triggers coordinated changes in the immune system within just a few weeks. 📰 @ard.eular.org
Show PostPlease help us by completing this survey on the availability, accessibility & affordability of #RA treatments across Europe. The results will help identify disparities in the treatment access across Europe & support future evidence-based recommendations for more equitable care. #EULAR2026
Show PostCan biomarkers and personalised care end years of trial and error for people with #rheumatoidarthritis? The EU-funded SQUEEZE project, coordinated by @danielaletaha.bsky.social from #MedUniVienna aims to optimise existing therapies and bring more patients into remission. ⬇️ #Rheumatology
Show Post🚀 Meet our supportive partner: @inmusc.bsky.social #InMusc is a Spanish consultancy that helps transform ideas into impact through research and #methodology training. Their mission is to make research collaborations agile, relevant, and meaningful.
Show PostJoin the 9th EULAR Course on Immunology 2026, a highly interactive course focused on key immunology concepts and practical research project design. 📅 6-7 February 2026 📍Amsterdam, Netherlands 🔔Registration deadline: 2 November 2025 Register here: https://pulse.ly/nul3x4sazs #eularEDUCATION
Show Post